Hazelton G A, Klaassen C D
Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City 66103.
Drug Metab Dispos. 1988 Jan-Feb;16(1):30-6.
Glucuronidation of digitoxigenin-monodigitoxoside (DT1), a metabolite of the cardiac glycoside digitoxin, is mediated by the microsomal isozymes, UDP-glucuronosyltransferase(s) (UDP-GT). The present studies examined the activation and induction properties of UDP-GT activity toward DT1 in hepatic microsomes of rats and mice. When compared to enzyme activity present in native (latent) microsomes of the rat (0.104 +/- 0.010 nmol/min/mg of protein), the activity toward digitoxigenin-monodigitoxoside in mouse native microsomes was 3.5-fold higher (0.379 + 0.44 mumol/min/mg of protein). After treatment with ionic (sodium cholate), zwitterionic [3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid (CHAPS)], or nonionic (Emulgen 911, Triton X-100) detergents, or with UDP-N-acetylglucosamine, enzyme activity in rat microsomes remained unchanged. In contrast, UDP-GT activity (DT1) in mouse liver microsomes treated with detergents or with the nucleotide was increased 2-3-fold above native enzyme activity. Pretreatment of rats with the microsomal enzyme inducers, 3-methylcholanthrene and phenobarbital, had no effect on this enzyme activity, whereas pretreatment with pregnenolone-16 alpha-carbonitrile (PCN) and dexamethasone (DEX) increased enzyme activity toward DT1 800 and 380%, respectively. These findings support the hypothesis that PCN and DEX induce a unique form of UDP-GT in the rat that selectively glucuronidates DT1. In marked contrast, the activity of this enzyme in mouse liver was not affected by pretreatment with any of the microsomal inducers, including PCN and DEX. In both rat and mouse, the P-450p-dependent N-ethylmorphine demethylase activity was increased 10-15-fold in PCN-pretreated animals.(ABSTRACT TRUNCATED AT 250 WORDS)
洋地黄毒苷元 - 单洋地黄毒糖苷(DT1)是强心苷洋地黄毒苷的一种代谢产物,其葡萄糖醛酸化作用由微粒体同工酶尿苷二磷酸葡萄糖醛酸基转移酶(UDP - GT)介导。本研究检测了大鼠和小鼠肝微粒体中UDP - GT对DT1活性的激活和诱导特性。与大鼠天然(潜在)微粒体中的酶活性(0.104±0.010 nmol/分钟/毫克蛋白质)相比,小鼠天然微粒体中对洋地黄毒苷元 - 单洋地黄毒糖苷的活性高3.5倍(0.379 + 0.44微摩尔/分钟/毫克蛋白质)。用离子型(胆酸钠)、两性离子型[3 - [(3 - 胆酰胺丙基)二甲基铵] - 1 - 丙烷磺酸(CHAPS)]或非离子型(乳化剂911、曲拉通X - 100)去污剂,或用尿苷二磷酸 - N - 乙酰葡糖胺处理后,大鼠微粒体中的酶活性保持不变。相反,用去污剂或核苷酸处理的小鼠肝微粒体中UDP - GT活性(DT1)比天然酶活性增加了2 - 3倍。用微粒体酶诱导剂3 - 甲基胆蒽和苯巴比妥预处理大鼠,对该酶活性没有影响,而用孕烯醇酮 - 16α - 腈(PCN)和地塞米松(DEX)预处理分别使对DT1的酶活性增加了800%和380%。这些发现支持了以下假设:PCN和DEX在大鼠中诱导出一种独特形式的UDP - GT,其能选择性地使DT1葡萄糖醛酸化。与之形成显著对比的是,该酶在小鼠肝脏中的活性不受包括PCN和DEX在内的任何微粒体诱导剂预处理的影响。在大鼠和小鼠中,经PCN预处理的动物中,依赖细胞色素P - 450p的N - 乙基吗啡脱甲基酶活性增加了10 - 15倍。(摘要截短至250字)